Shandong Weigao Inks $312M Deal To Sell Biosensors Stake

Law360, New York (November 22, 2013, 4:39 PM EST) -- Chinese medical products company Shandong Weigao Group Medical Polymer Co. Ltd. said Thursday it is selling its entire 21.7 percent stake in medical device maker Biosensors International Group Ltd. for $312.3 million, citing a need to consolidate business.

Weigao Group, through its subsidiary Wellford Capital Ltd., has entered into a purchase and sale agreement to sell its interest in Biosensors to CB Medical Holdings Ltd. for S$1.05 (84 cents) per share, an 11.7 percent premium on the last closing price, the company said in a statement....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.